Technology enabling thermally-controlled DNA synthesis
April 5, 2022Manufacturing and Production
Evonetix has been granted a patent in Europe for thermal control technology for DNA synthesis, as well as the design …
NHS struggling to make progress on early cancer diagnosis
April 5, 2022Manufacturing and Production
MPs have warned that the NHS in England is struggling to make progress on its flagship target to diagnose three-quarters …
FDA approves generic version of brain imaging agent in US
April 5, 2022Manufacturing and Production
The FDA has approved the generic version of DaTscan (Ioflupane I 123), manufactured and commercialised by Curium. This is a …
FlyPharma Conference Europe: New dates and location announced
April 4, 2022Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.
AI test could predict effective cancer drug combinations in less than two days
April 4, 2022Sales and Marketing
Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in …
FDA accepts Dupixent for Priority Review in patients 12+ with eosinophilic esophagitis
April 4, 2022Sales and Marketing
The FDA has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab), in patients aged 12 …
New centre targets ‘undruggable’ cancers
April 4, 2022Sales and Marketing
The new Centre for Protein Degradation has been launched, made possible by a £9 million donation to The Institute of …
COVID-19 vaccines now available for five to 11-year olds in England
April 4, 2022Sales and Marketing
Parents and carers of five to 11-year olds in England can now book a low-dose COVID-19 vaccine for their children. …
FDA places two clinical holds on CytoDyn HIV and COVID-19 programmes
April 1, 2022Medical Communications
The FDA has placed a partial hold on CytoDyn’s HIV program, and a full clinical hold on its COVID-19 program …
Biomodex launches clear cartridges for neurovascular training
April 1, 2022Medical Communications
Biomodex has announced the launch of clear cartridges for use with Biomodex’s EVIAS and EVIAS Plus stations.The cartridges are 3D …
Isturisa effective in treating rare Cushing’s disease
April 1, 2022Medical Communications
Recordati Rare Diseases has announced the publication of positive results from the Phase III LNC 4 study, confirming the efficacy …
UK app launched for people living with glaucoma
April 1, 2022Medical Communications
Santen UK has launched a new app for people living with glaucoma, in partnership with Glaucoma UK, the leading charity …
New research finds patient satisfaction with GP services has dropped since pre-pandemic
March 31, 2022GP leaders have said that it is ‘unsurprising’ that more people are dissatisfied with the NHS than are satisfied, and …
FDA approval of Cabenuva for adolescents living with HIV
March 31, 2022Business Services
ViiV Healthcare, the global specialist HIV company, today announced the FDA approval of Cabenuva (cabotegravir, rilpivirine), for the treatment of …
Carteyva receives IND approval for clinical trial in second-line large b-cell lymphoma
March 31, 2022Business Services
An investigational new drug (IND) clearance from the National Medical Products Administration (NMPA) of China, for a pivotal clinical trial …
250,000 with diabetes to benefit from real time information after updated NICE recommendations
March 31, 2022Business Services
Over 250,000 people living with type 1 diabetes are set to be offered new technology to help them manage their …
Kesimpta-treated adults with multiple sclerosis not at risk of severe COVID-19
March 30, 2022Business Services
The peer-reviewed journal Neurology and Therapy has published new data on COVID-19 infections in people living with remitting multiple sclerosis …
Carthera’s SonoCloud demonstrates potential in Alzheimer’s patients
March 30, 2022Business Services
Carthera has announced the publication of results in the Alzheimer’s Research & Therapy Journal, from an investigator-sponsored trial evaluating the …
Iktos announces a collaboration with Ono for new drug design
March 30, 2022Research and Development
Iktos, a company specialised in AI for new drug design today announced a collaboration agreement with Ono Pharmaceuticals, on innovative …
$24 million in grants to help end HIV epidemic across the globe
March 30, 2022Research and Development
Gilead Sciences announced $24 million in grants to help reduce health disparities, improve access to quality healthcare, advance medical education, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
